Hilary Lewis
Directeur/Bestuurslid bij Perseis Therapeutics Ltd.
Profiel
Hilary Lewis is currently a Director at Perseis Therapeutics Ltd.
and a Member at The Institute of Directors.
In the past, she was a Director at Pathway Therapeutics, Inc. and Pathway Therapeutics Ltd.
She also held the position of eCommerce Director at House of Travel Holdings Ltd.
from 2004 to 2008.
Additionally, she was a Director at The Breast Cancer Research Trust and a Principal at Air New Zealand Ltd.
Actieve functies van Hilary Lewis
Bedrijven | Functie | Begin |
---|---|---|
The Institute of Directors
The Institute of Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Directors provides informative events and professional development courses. The non-profit company is based in Johannesburg, South Africa. Parmesvari Natesan has been the CEO of the South African company since 2010. | Corporate Officer/Principal | 23-04-2010 |
Perseis Therapeutics Ltd. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Hilary Lewis
Bedrijven | Functie | Einde |
---|---|---|
House of Travel Holdings Ltd.
House of Travel Holdings Ltd. House of Travel Holdings Ltd. provides tourism services. The company is headquartered in Christchurch, New Zealand. | Corporate Officer/Principal | 01-01-2008 |
AIR NEW ZEALAND LIMITED | Corporate Officer/Principal | - |
The Breast Cancer Research Trust
The Breast Cancer Research Trust Medical SpecialtiesHealth Technology The Breast Cancer Research Trust operates as not-for profit organization. It provides breast cancer treatment solutions. The company was founded in 1997 and is headquartered in Auckland, New Zealand. | Directeur/Bestuurslid | - |
Pathway Therapeutics, Inc.
Pathway Therapeutics, Inc. BiotechnologyHealth Technology Pathway Therapeutics, Inc. operates as a clinical stage, privately held, pharmaceutical company developing differentiated and best in class isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory diseases. Its lead product include PWT33597, demonstrates excellent in vitro selectivity for its targets, with negligible activity against other protein kinases and other pharmacologically relevant targets at biologically active concentrations. The firm’s other product include PWT143, which has shown outstanding efficacy in in vivo models and has an excellent DMPK and safety profile suitable for advancement in multiple indications. The company was founded in 2010 by William A. Denny and Peter Robin Shepherd and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | - |
Pathway Therapeutics Ltd.
Pathway Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Pathway Therapeutics Ltd. developed drugs for the treatment of cancer. The company was founded in 2007 and was headquartered in Auckland, New Zealand. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AIR NEW ZEALAND LIMITED | Transportation |
Bedrijven in privébezit | 6 |
---|---|
Pathway Therapeutics Ltd.
Pathway Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Pathway Therapeutics Ltd. developed drugs for the treatment of cancer. The company was founded in 2007 and was headquartered in Auckland, New Zealand. | Health Technology |
The Institute of Directors
The Institute of Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Directors provides informative events and professional development courses. The non-profit company is based in Johannesburg, South Africa. Parmesvari Natesan has been the CEO of the South African company since 2010. | Commercial Services |
House of Travel Holdings Ltd.
House of Travel Holdings Ltd. House of Travel Holdings Ltd. provides tourism services. The company is headquartered in Christchurch, New Zealand. | |
Pathway Therapeutics, Inc.
Pathway Therapeutics, Inc. BiotechnologyHealth Technology Pathway Therapeutics, Inc. operates as a clinical stage, privately held, pharmaceutical company developing differentiated and best in class isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory diseases. Its lead product include PWT33597, demonstrates excellent in vitro selectivity for its targets, with negligible activity against other protein kinases and other pharmacologically relevant targets at biologically active concentrations. The firm’s other product include PWT143, which has shown outstanding efficacy in in vivo models and has an excellent DMPK and safety profile suitable for advancement in multiple indications. The company was founded in 2010 by William A. Denny and Peter Robin Shepherd and is headquartered in San Francisco, CA. | Health Technology |
The Breast Cancer Research Trust
The Breast Cancer Research Trust Medical SpecialtiesHealth Technology The Breast Cancer Research Trust operates as not-for profit organization. It provides breast cancer treatment solutions. The company was founded in 1997 and is headquartered in Auckland, New Zealand. | Health Technology |
Perseis Therapeutics Ltd. |